Stem Cell Research (Oct 2019)

Generation of three iPSC lines (IAIi002, IAIi004, IAIi003) from Rubinstein-Taybi syndrome 1 patients carrying CREBBP non sense c.4435G>T, p.(Gly1479*) and c.3474G>A, p.(Trp1158*) and missense c.4627G>T, p.(Asp1543Tyr) mutations

  • Valentina Alari,
  • Silvia Russo,
  • Davide Rovina,
  • Maria Garzo,
  • Milena Crippa,
  • Luciano Calzari,
  • Claudia Scalera,
  • Daniela Concolino,
  • Elisa Castiglioni,
  • Daniela Giardino,
  • Ennio Prosperi,
  • Palma Finelli,
  • Cristina Gervasini,
  • Aoife Gowran,
  • Lidia Larizza

Journal volume & issue
Vol. 40

Abstract

Read online

Rubinstein-Taybi syndrome (RSTS) is a neurodevelopmental disorder characterized by growth retardation, skeletal anomalies and intellectual disability, caused by heterozygous mutations in either CREBBP (RSTS1) or EP300 (RSTS2) genes. We characterized 3 iPSC lines generated by Sendai from blood of RSTS1 patients with unique non sense c.4435G > T, p.(Gly1479*), c.3474G > A, p.(Trp1158*) and missense c.4627G > T, p.(Asp1543Tyr) CREBBP mutations. All lines displayed iPSC morphology, pluripotency markers, trilineage differentiation potential, stable karyotype and specific mutations. Western-blot using a CREB-Binding Protein N-terminus antibody demonstrated the same amount of full length protein as control in the missense mutation line and reduced amount in lines with stop mutations.